Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)
Sector: Health Care
Market cap: A$22.4B (as of 2 Nov 2026)
Fisher & Paykel Healthcare is a world leader in medical devices and systems for use in respiratory care, acute care, surgery and in the treatment of obstructive sleep apnea. Our products are sold in more than 120 countries around the world and we estimate
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 18 May 2026 | PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED (AND ITS SUBSIDIARIES LISTED IN ANNEXURE A) | Entry | ?% → 5.015% | Filing ↗ |
| 2 Apr 2026 | Justin Peter Callahan | Unknown | — | Filing ↗ |
| 17 Mar 2026 | Pinnacle Investment Management Group Limited | Exit | 5.0487% → 4.9754% | Filing ↗ |
| 2 Feb 2026 | Anna Valerie Curzon | Unknown | — | Filing ↗ |
| 30 Jan 2026 | Pinnacle Investment Management Group Limited | Entry | ?% → 5.0487% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 12 Sept 2024 | Graham Andrew McLean | Bought 800 Ordinary Shares | Filing ↗ |
| 11 Sept 2024 | Andrew Grant Niccol | Sold 650 Ordinary Shares | Filing ↗ |
| 1 June 2022 | Scott Andrew St John | Bought 500 | Filing ↗ |
| 14 Sept 2020 | Andrew Robert Donald Somervell | Sold 52,000 | Filing ↗ |
| 10 Sept 2020 | Paul Nigel Shearer | Sold 39,500 | Filing ↗ |
Latest guidance
| Date | Period | Guidance | Source |
|---|---|---|---|
| 21 Aug 2026 | FY27 | The full year outlook continues to anticipate an overall improvement in gross margin and also assumes current global tariff rates, policies and applications for the duration of this financial year. | Filing ↗ |
Ask about FPH in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has FPH raised money in the last year, and at what discount?
- What was FPH's latest cash position and runway?
Loading FPH…